NEMHESYS—European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics

Autor: Inmaculada Serramito-Gómez, Kathryn M. Clarke, Ana Eugenia Rodríguez-Vicente, Julie E. McGimpsey, María Abáigar, Carlos Barranquero Díez, Rocío Benito, Lars Bullinger, Ken I. Mills, Jesús María Hernández Rivas

Publikováno v: HemaSphere, Vol 5, Iss 3, p e541 (2021)

Externí odkaz: https://doaj.org/article/85780076835943e3956a4a40756d5f73

NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics

Autor: Jesús María Hernández Rivas, Ken I. Mills, Rocío Benito, María Abáigar, Inmaculada Serramito-Gómez, Ana E. Rodríguez-Vicente, Julie E. McGimpsey, Carlos Barranquero Díez, Lars Bullinger, Kathryn M. Clarke

Publikováno v: Serramito-Gómez, I, Clarke, K M, Rodríguez-Vicente, A E, McGimpsey, J E, Abáigar, M, Díez, C B, Benito, R, Bullinger, L, Mills, K I & Hernández Rivas, J M 2021, ' NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics ', HemaSphere, vol. 5, no. 3, e541 . https://doi.org/10.1097/HS9.0000000000000541
Digital.CSIC. Repositorio Institucional del CSIC
instname
HemaSphere
HemaSphere, Vol 5, Iss 3, p e541 (2021)

© 2021 the Author(s).
NGS Establishment in Multidisciplinary Healthcare (NEMHESYS) is an Erasmus+ programme with the purpose of providing qualified staff with the essential technical and bioinformatic knowledge and skills on next-generation seq

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af98b691c2bf8c78094e8b807828ab56
https://pure.qub.ac.uk/en/publications/b5260283-baa4-435d-b4a7-47cb4e400ccb

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered Histone H3K9 marks in myeloid leukaemia cells

Autor: Ken I. Mills, Fabio G. Liberante, Christine S. Young, Alexander Thompson, Kathryn M. Clarke, Mary Frances McMullin

Publikováno v: Clarke, K, Young, C, Liberante, F, McMullin, M, Thompson, A & Mills, K 2019, ' The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered Histone H3K9 marks in myeloid leukaemia cells ', Oncotarget, vol. 10, no. 37, pp. 3462-3471 . https://doi.org/10.18632/oncotarget.26877, https://doi.org/10.18632/oncotarget.26877
Oncotarget

© 2020 Ivyspring International Publisher. All rights reserved. Myelodysplastic syndromes (MDS) are a heterogeneous, clonal haematopoietic disorder, with ~1/3 of patients progressing to acute myeloid leukaemia (AML). Many elderly MDS patients do not

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d29ba2569b49aaea963e5f17b4cf4cad
https://pure.qub.ac.uk/en/publications/the-histone-deacetylase-inhibitor-romidepsin-induces-as-a-cascade-of-differential-gene-expression-and-altered-histone-h3k9-marks-in-myeloid-leukaemia-cells(4a6b7aac-ff98-4856-9980-d38d89777f5c).html